Granite Shares Advisors LLC Neurocrine Biosciences Inc Transaction History
Granite Shares Advisors LLC
- $149 Million
- Q2 2025
A detailed history of Granite Shares Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Granite Shares Advisors LLC holds 3,174 shares of NBIX stock, worth $425,919. This represents 0.27% of its overall portfolio holdings.
Number of Shares
3,174
Previous 3,111
2.03%
Holding current value
$425,919
Previous $344,000
15.7%
% of portfolio
0.27%
Previous 0.24%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
653Shares Held
96.6MCall Options Held
800KPut Options Held
565K-
Black Rock Inc. New York, NY14.2MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.33 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$743 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$652 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$358 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...